Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response.
Omid HamidRené BrunoMarcella FassoCarol O'HearBenjamin WuPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)